55. Wallrabe H, Periasamy A (2005) Imaging protein molecules using FRET and FLIM microscopy. Curr Opin Biotechnol 16:19–27
56. Ackroyd R, Kelty C, Brown N, Reed M (2001) The history of photodetection and photodynamic therapy. Photochem Photobiol 74:656–669
57. Auler H, Banzer G (1942) Untersuchungen über die Rolle der Porphyrine bei
geschwulstkranken Menschen und Tieren. Z Krebsforsch 53:65–68
58. Josefsen LB, Boyle RW (2008) Photodynamic therapy and the development of metal-based
photosensitisers. Met Based Drugs 2008:276109
59. Wilson BC, Patterson MS (2008) The physics, biophysics and technology of photodynamic
therapy. Phys Med Biol 53:R61–R109
60. Blake E, Allen J, Curnow A (2011) An in vitro comparison of the effects of the iron-chelating
agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy
and/or fluorescence guided resection. Photochem Photobiol 87:1419–1426
61. Winkelman J (1962) The distribution of tetraphenylporphinesulfonate in the tumor-bearing rat.
Cancer Res 22:589–596
62. Lovell JF et al (2011) Porphysome nanovesicles generated by porphyrin bilayers for use as
multimodal biophotonic contrast agents. Nat Mater 10:324–332
63. Huang H et al (2017) Implantable tin porphyrin-PEG hydrogels with pH-responsive fluorescence. Biomacromolecules 18:562–567
64. Huang H et al (2014) Pd-porphyrin-cross-linked implantable hydrogels with oxygenresponsive phosphorescence. Adv Healthc Mater 3:891–896
65. Wong RCH, Lo P-C, Ng DKP (2019) Stimuli responsive phthalocyanine-based fluorescent
probes and photosensitizers. Coord Chem Rev 379:30–46
66. van Leengoed HL et al (1994) In vivo fluorescence and photodynamic activity of zinc
phthalocyanine administered in liposomes. Br J Cancer 69:840–845
67. Taratula O et al (2015) Naphthalocyanine-based biodegradable polymeric nanoparticles for
image-guided combinatorial phototherapy. Chem Mater 27:6155–6165
68. Gasser M, Waaga-Gasser AM (2016) Therapeutic antibodies in cancer therapy. Adv Exp Med
Biol 917:95–120
69. Fay F, Scott CJ (2011) Antibody-targeted nanoparticles for cancer therapy. Immunotherapy
3:381–394
70. Alibakhshi A et al (2017) Targeted cancer therapy through antibody fragments-decorated
nanomedicines. J Control Release 268:323–334
71. Hollandsworth HM et al (2019) Anti-Claudin-1 conjugated to a near-infrared Fluorophore
targets colon cancer in PDOX mouse models. J Surg Res 242:145–150
72. Maawy AA et al (2015) Near infra-red photoimmunotherapy with anti-CEA-IR700 results in
extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models
of pancreatic cancer. PLoS One 10:e0121989
73. Hiroshima Y et al (2015) Photoimmunotherapy inhibits tumor recurrence after surgical
resection on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse
model. Ann Surg Oncol 22(Suppl 3):S1469–S1474
74. Boogerd LSF et al (2018) Safety and effectiveness of SGM-101, a fluorescent antibody
targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a doseescalation pilot study. Lancet Gastroenterol Hepatol 3:181–191
75. Kijanka M et al (2013) Rapid optical imaging of human breast tumour xenografts using antiHER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery. Eur J Nucl
Med Mol Imaging 40:1718–1729
76. van der Vorst JR et al (2013) Near-infrared fluorescence-guided resection of colorectal liver
metastases. Cancer 119:3411–3418
77. van der Vorst JR et al (2011) Optimization of near-infrared fluorescent sentinel lymph node
mapping in cervical cancer patients. Int J Gynecol Cancer 21:1472–1478
78. Crane LMA et al (2011) Intraoperative multispectral fluorescence imaging for the detection of
the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol 13:1043–1049
50
X. Yang et al.
56. Ackroyd R, Kelty C, Brown N, Reed M (2001) The history of photodetection and photodynamic therapy. Photochem Photobiol 74:656–669
57. Auler H, Banzer G (1942) Untersuchungen über die Rolle der Porphyrine bei
geschwulstkranken Menschen und Tieren. Z Krebsforsch 53:65–68
58. Josefsen LB, Boyle RW (2008) Photodynamic therapy and the development of metal-based
photosensitisers. Met Based Drugs 2008:276109
59. Wilson BC, Patterson MS (2008) The physics, biophysics and technology of photodynamic
therapy. Phys Med Biol 53:R61–R109
60. Blake E, Allen J, Curnow A (2011) An in vitro comparison of the effects of the iron-chelating
agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy
and/or fluorescence guided resection. Photochem Photobiol 87:1419–1426
61. Winkelman J (1962) The distribution of tetraphenylporphinesulfonate in the tumor-bearing rat.
Cancer Res 22:589–596
62. Lovell JF et al (2011) Porphysome nanovesicles generated by porphyrin bilayers for use as
multimodal biophotonic contrast agents. Nat Mater 10:324–332
63. Huang H et al (2017) Implantable tin porphyrin-PEG hydrogels with pH-responsive fluorescence. Biomacromolecules 18:562–567
64. Huang H et al (2014) Pd-porphyrin-cross-linked implantable hydrogels with oxygenresponsive phosphorescence. Adv Healthc Mater 3:891–896
65. Wong RCH, Lo P-C, Ng DKP (2019) Stimuli responsive phthalocyanine-based fluorescent
probes and photosensitizers. Coord Chem Rev 379:30–46
66. van Leengoed HL et al (1994) In vivo fluorescence and photodynamic activity of zinc
phthalocyanine administered in liposomes. Br J Cancer 69:840–845
67. Taratula O et al (2015) Naphthalocyanine-based biodegradable polymeric nanoparticles for
image-guided combinatorial phototherapy. Chem Mater 27:6155–6165
68. Gasser M, Waaga-Gasser AM (2016) Therapeutic antibodies in cancer therapy. Adv Exp Med
Biol 917:95–120
69. Fay F, Scott CJ (2011) Antibody-targeted nanoparticles for cancer therapy. Immunotherapy
3:381–394
70. Alibakhshi A et al (2017) Targeted cancer therapy through antibody fragments-decorated
nanomedicines. J Control Release 268:323–334
71. Hollandsworth HM et al (2019) Anti-Claudin-1 conjugated to a near-infrared Fluorophore
targets colon cancer in PDOX mouse models. J Surg Res 242:145–150
72. Maawy AA et al (2015) Near infra-red photoimmunotherapy with anti-CEA-IR700 results in
extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models
of pancreatic cancer. PLoS One 10:e0121989
73. Hiroshima Y et al (2015) Photoimmunotherapy inhibits tumor recurrence after surgical
resection on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse
model. Ann Surg Oncol 22(Suppl 3):S1469–S1474
74. Boogerd LSF et al (2018) Safety and effectiveness of SGM-101, a fluorescent antibody
targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a doseescalation pilot study. Lancet Gastroenterol Hepatol 3:181–191
75. Kijanka M et al (2013) Rapid optical imaging of human breast tumour xenografts using antiHER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery. Eur J Nucl
Med Mol Imaging 40:1718–1729
76. van der Vorst JR et al (2013) Near-infrared fluorescence-guided resection of colorectal liver
metastases. Cancer 119:3411–3418
77. van der Vorst JR et al (2011) Optimization of near-infrared fluorescent sentinel lymph node
mapping in cervical cancer patients. Int J Gynecol Cancer 21:1472–1478
78. Crane LMA et al (2011) Intraoperative multispectral fluorescence imaging for the detection of
the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol 13:1043–1049
50
X. Yang et al.